Serial 87608501
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Nov 2024)
What this means for you
Registered since 26 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87608501
- Registration number
- 5501132
- Mark type
- Design / logo
- Filed
- 14 Sept 2017
- Published for opposition
- 10 Apr 2018
- Registered
- 26 Jun 2018
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of leukemia, other cancers, [ and auto-immune diseases; ] pharmaceutical preparations, namely, cytokine inhibitory drugs [ ; pharmaceutical preparations that modulate the immune system ]
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prosecution history
- 23 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 26 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 10 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Apr 2018 — PUBLISHED FOR OPPOSITION
- 21 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED